The global pharma grade sodium bicarbonate market is poised for robust growth, with sales expected to surpass US$ 256.0 million in 2022 and projected to reach US$ 315.4 million by 2028, exhibiting a steady CAGR of 3.5%. This expansion is fueled by increasing demand for pharmaceutical-grade sodium bicarbonate across various applications, driven by its versatile properties and widespread usage in pharmaceutical formulations. Factors such as growing healthcare awareness, rising prevalence of diseases, and technological advancements in pharmaceutical manufacturing processes are anticipated to further propel market growth during the forecast period.
Pharma grade sodium bicarbonate, also known as baking soda, is a white crystalline powder that is widely used in the pharmaceutical industry. It is commonly used as an antacid, a buffering agent, and a source of carbon dioxide for medicinal purposes. It is also used in the manufacturing of various drugs, including aspirin, antihistamines, and antibiotics.
Request a Sample Report and Explore New Growth Opportunities Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-6826
Pharma grade sodium bicarbonate is manufactured under strict quality control standards to ensure its purity and consistency. It is produced through a chemical reaction between sodium carbonate and carbon dioxide, followed by a purification process to remove any impurities. The resulting product is a highly pure form of sodium bicarbonate with a minimum purity of 99.5%.
Administering Sodium Bicarbonate to Pregnant Women Found Effective in Inducing Natural Childbirth
Researchers from the University of Liverpool and Karolinska Institute in Sweden have discovered that giving pharma grade sodium bicarbonate to women in labour would increase their chances of having a natural, vaginal delivery. A set of women were given pharma grade sodium bicarbonate along with oxytocin and another set was only given oxytocin – a drug that helps strengthen contractions. It was found that the intake of bicarbonate of soda increased the chances of a vaginal delivery by 17% as compared to only administering oxytocin that helped in labour contraction in very few cases, leaving emergency caesarean section as the only option for the other cases. According to researchers, this kind of therapeutic use of pharma grade sodium bicarbonate will decrease Amniotic Fluid Lactate (AFL) – high levels of which mostly lead to operative interventions.
In another study, pharma grade sodium bicarbonate, when taken as a supplement by young swimmers, was found to increase their performance by regulating the blood buffering power. Also, when athletes took this compound in controlled measures, they displayed reduced signs of lactate concentration and digestive symptoms such as cramps and abdominal pain.
Developing Pharmaceutical Sector in Certain Countries Anticipated to Attract Huge Global Investments
Low cost treatments using pharma grade sodium bicarbonate have the potential to improve mortality rates in developing nations with a thriving pharmaceutical sector. This is projected to create traction in the global market for pharma grade sodium bicarbonate therapeutics. Additionally, favourable government policies including those pertaining to foreign direct investments, healthcare facilities and infrastructure development programmes such as cluster development in the pharmaceuticals sector are likely to trigger revenue growth of the global pharma grade sodium bicarbonate market.
The demand for pharmaceutical grade sodium bicarbonate is largely driven by increasing healthcare expenditure and rising demand for pharmaceutical products utilising sodium bicarbonate.
Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights: https://www.futuremarketinsights.com/checkout/6826
Competition Landscape
Key players operating in the global pharma grade sodium bicarbonate market are focusing on new product launches in the form of injections for the medical industry worldwide. They are also engaging in collaborations, mergers, acquisitions, and joint ventures to distribute their products in numerous healthcare institutions to cater to the high demand from consumers. Meanwhile, some of the other companies are aiming to conduct exhaustive research and development activities to introduce innovative sodium bicarbonate medications for various disorders.
Top Key Players
- Solvay SA
- Tata Chemicals
- Novacarb (Novacap Group)
- Dr. Paul Lohmann GmbH KG
- GHCL Limited
- CIECH S.A.
- Natural Soda LLC
- Jost Chemical Co.
- Tronox Alkali Corporation
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube